Zyprexa Settlement With W. Virginia Shows States Can Benefit In Solo Suits
Executive Summary
Lilly's $22.5 million settlement with West Virginia to resolve litigation over its Zyprexa marketing shows the benefit for states in pursuing suits against pharmaceutical manufacturers on their own